CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 53 enrolled
Drug / intervention
Magnetic irrigated ablation catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00851279
NCT00851279Phase 4Completed

Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia: Data Collection of Clinical Scar-related VT Cases

Stereotaxis·interventional·Posted Feb 25, 2009·Updated Aug 24, 2015

In Brief

A Phase 4 clinical trial evaluating Magnetic irrigated ablation catheter for Ventricular Tachycardia. Completed, enrolled 53 participants across 4 sites in 3 countries.

Detailed Summary

This is a prospective, non-randomized, multi-center clinical case series evaluating the outcomes of the magnetic navigation system in ventricular tachycardia (VT) cases. Subjects will be evaluated acutely and will be followed clinically at 1, 6 and 12 months post-treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCzechia, Germany, United States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 25, 2009
Enrollment StartJun 1, 2009
Primary CompletionOct 1, 2012
Study CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 17.4 years ago

Interventions

Magnetic irrigated ablation catheterdevice

Magnetic irrigated catheter to be used with the magnetic navigation system